ABYNTEK | Tumor markers for cancer research: FAQS
Stage-stratified molecular profiling of non-muscle-invasive bladder cancer enhances biological, clinical, and therapeutic insight - ScienceDirect
Multiple recurrences and risk of disease progression in patients with primary low-grade (TaG1) non–muscle-invasive bladder cancer and with low and intermediate EORTC-risk score | PLOS ONE
Urinary TERT promoter mutations are detectable up to 10 years prior to clinical diagnosis of bladder cancer: Evidence from the Golestan Cohort Study - eBioMedicine
Tumor Markers - Priority Health
Biological Markers in the Diagnosis of Recurrent Bladder Cancer
Diagnostics | Free Full-Text | Biomarkers for Bladder Cancer Diagnosis and Surveillance: A Comprehensive Review
Artificial intelligence: A promising frontier in bladder cancer diagnosis and outcome prediction - ScienceDirect
Non muscle invasive bladder cancer treatment - WCRJ
Useful and potentially useful urine markers for bladder cancer. | Download Table
Bladder Cancer Markers and Recent Innovations | IntechOpen
Bladder Cancer Survival: The Importance of Early Detection | Cxbladder
JCI - Urine DNA methylation assay enables early detection and recurrence monitoring for bladder cancer
FEP 2.04.07 Urinary Biomarkers for Cancer Screening, Diagnosis, and Surveillance
Cancers | Free Full-Text | Noninvasive Urine-Based Tests to Diagnose or Detect Recurrence of Bladder Cancer
Recurrent Bladder Cancer - CancerConnect
Prognostic urinary biomarkers for bladder cancer | Download Table
Dr. Peter Black | Urine Markers for Bladder Cancer | The Ideal Marker
Frontiers | Detecting and monitoring bladder cancer with exfoliated cells in urine
Cells | Free Full-Text | Emerging Roles of Cancer Stem Cells in Bladder Cancer Progression, Tumorigenesis, and Resistance to Chemotherapy: A Potential Therapeutic Target for Bladder Cancer
Assessment of prognostic implication of a panel of oncogenes in bladder cancer and identification of a 3-gene signature associated with recurrence and progression risk in non-muscle-invasive bladder cancer | Scientific Reports
Cepheid | Bladder Cancer Monitor Biomarker Test - Xpert Bladder Cancer Monitor
Urinary peptide panel for prognostic assessment of bladder cancer relapse | Scientific Reports
Gender-specific Differences in Recurrence of Non–muscle-invasive Bladder Cancer: A Systematic Review and Meta-analysis - European Urology Focus
Diagnosis of Bladder Cancer Recurrence Based on Urinary Levels of EOMES, HOXA9, POU4F2, TWIST1, VIM, and ZNF154 Hypermethylation | PLOS ONE
Non muscle invasive bladder cancer treatment - WCRJ
Tumor immune microenvironment-based classifications of bladder cancer for enhancing the response rate of immunotherapy: Molecular Therapy - Oncolytics
